Research graph
References from Comparing the efficacy of first-line immunotherapies in autoimmune encephalitis: a scoping review. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2023 · External reference
Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis
10.3174/ajnr.a5086 · 2017 · External reference
The diagnosis and treatment of autoimmune encephalitis
10.3988/jcn.2016.12.1.1 · 2016 · External reference
A clinical approach to diagnosis of autoimmune encephalitis
10.1016/s1474-4422(15)00401-9 · 2016 · External reference
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
10.1016/s1474-4422(12)70310-1 · 2013 · External reference
Immunotherapy for autoimmune encephalitis
10.1038/s41420-025-02459-z · 2025 · External reference
Autoimmune encephalitis: a physician’s guide to the clinical spectrum diagnosis and management
10.3390/brainsci12091130 · 2022 · External reference
Prisma extension for scoping reviews (PRISMA-SCR): checklist and explanation
10.7326/m18-0850 · 2018 · External reference
Scoping studies: towards a methodological framework
10.1080/1364557032000119616 · 2005 · External reference
Modified Rankin scale is a reliable tool for the rapid assessment of stroke severity and predicting disability outcomes
10.4103/jfmpc.jfmpc_1431_23 · 2024 · External reference
First-line immunotherapy of neuronal surface antibody-mediated autoimmune encephalitis: assessment of therapeutic effectiveness and cost-efficiency
10.1016/j.msard.2022.104071 · 2022 · External reference
Clinical characterization of autoimmune LGI1 antibody limbic encephalitis
10.1016/j.yebeh.2015.12.041 · 2016 · External reference
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and caspr2
10.1007/s00415-025-13032-0 · 2025 · External reference
Efficacy and tolerability of intravenous immunoglobulin versus intravenous methylprednisolone treatment in anti-n-methyl-d-aspartate receptor encephalitis
10.1111/ene.15214 · 2022 · External reference
Autoimmune encephalitis in a tertiary hospital in the Philippines
10.1016/j.jocn.2021.05.052 · 2021 · External reference
Autoimmune encephalitis and immune therapy: lessons from Argentina
10.1007/s13760-018-1013-x · 2018 · External reference
VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy
10.1016/j.jneuroim.2013.10.005 · 2013 · External reference
LGI1 antibody encephalitis: acute treatment comparisons and outcome
10.1136/jnnp-2021-327302 · 2021 · External reference
Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/Caspr2 antibodies
10.1016/j.jns.2018.05.020 · 2018 · External reference
The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
10.1002/acn3.51540 · 2022 · External reference
LGI1 antibody encephalitis – detailed clinical, laboratory and radiological description of 13 cases in China
10.1016/j.comppsych.2017.11.002 · 2018 · External reference
Therapeutic plasma exchange as a treatment for autoimmune neurological disease
10.1155/2020/3484659 · 2020 · External reference
Clinical efficacy of plasma exchange in patients with autoimmune encephalitis
10.1002/acn3.51313 · 2021 · External reference
Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study
10.1007/s00415-016-8277-y · 2016 · External reference
Acute and long-term immune-treatment strategies in anti-LGI1 antibody–mediated encephalitis
10.1212/nxi.0000000000200412 · 2025 · External reference
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
10.1136/jnnp-2020-325300 · 2021 · External reference
Autoimmune encephalitis in older adults: atypical presentation, therapeutic approaches and implication for diagnostic criteria
10.1016/j.jns.2026.126126 · 2026 · External reference
A systematic review of the epidemiology of pediatric autoimmune encephalitis: disease burden and clinical decision-making
10.3389/fneur.2024.1408606 · 2024 · External reference
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
10.1002/ana.25131 · 2018 · External reference
Google scholar is not enough to be used alone for systematic reviews
10.5210/ojphi.v5i2.4623 · 2013 · External reference
The role of Google scholar in evidence reviews and its applicability to grey literature searching
10.1371/journal.pone.0138237 · 2015 · External reference
Update on the diagnosis and management of autoimmune encephalitis
10.7861/clinmed.2020-0241 · 2020 · External reference
Modified zipper method, a promising treatment option in severe pediatric immune-mediated neurologic disorders
10.1177/08830738221089476 · 2022 · External reference
The prisma 2020 statement: An updated guideline for Reporting Systematic Reviews
10.1136/bmj.n71 · 2021 · External reference
